In the new episode of our podcast – The Zebras Herd – we're joined by Terry Pirovolakis, CEO of Elpida Therapeutics.
Terry achieved what many parents in the ultrarare-disease community aspire to do: develop a therapy for his son. He sat down to discuss with us the lessons he learned as he navigated the whole drug-discovery process in less than two years, laying out the foundation for what now is Elpida.
The thoughts and views represented by individuals in this podcast are their individual opinions only and are not necessarily representative of the thoughts and views their respective employers or organizations.
